Treat-to-Target With Actemra Succeeds in RA

(MedPage Today) -- Treating rheumatoid arthritis with tocilizumab (Actemra) only until remission was achieved allowed many patients to achieve sustained remission, and some were able to stop treatment altogether for short periods.
Source: MedPage Today Primary Care - Category: Primary Care Source Type: news